"A Study of Efficacy and Safety of On-demand Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)"
PHASE3CompletedINTERVENTIONAL
Enrollment
422
Participants
Timeline
Start Date
October 31, 2001
Study Completion Date
October 31, 2002
Conditions
Gastroesophageal RefluxHeartburn
Interventions
DRUG
rabeprazole
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT00236392 - "A Study of Efficacy and Safety of On-demand Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)" | Biotech Hunter | Biotech Hunter